קונבריזה

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

BAZEDOXIFENE AS ACETATE 20 MG

Tersedia dari:

NEOPHARM LTD

Kode ATC:

G03XC02

Bentuk farmasi:

COATED TABLETS

Rute administrasi :

PER OS

Diproduksi oleh:

PFIZER IRELAND PHARMACEUTICALS

Kelompok Terapi:

BAZEDOXIFENE

Indikasi Terapi:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Tanggal Otorisasi:

2013-04-01